A real-world study of antifibrotic drugs-related adverse events based on the United States food and drug administration adverse event reporting system and VigiAccess databases [PDF]
M. He +4 more
openalex +1 more source
Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database [PDF]
Jyotirmoy Sarker +3 more
openalex +1 more source
Four Food and Drug Administration draft guidance documents and the REGROW Act: A litmus test for future changes in human cell- and tissue-based products regulatory policy in the United States? [PDF]
, 2018 Kazuo Yano +2 more
openalex +1 more source
Rheumatic and Musculoskeletal Adverse Events with Immune Checkpoint Inhibitors: Data from the United States Food and Drug Administration Adverse Event Reporting System [PDF]
, 2019 Xerxes Pundole +2 more
openalex +1 more source
Make Up for Lost Time and Money: Using the Lanham Act to Regulate the Cosmetic Industry
, 2018 In recent years, the cosmetic industry has experienced an increase in litigation brought on by consumers in their efforts to protect themselves from cosmetics that are either unsafe or falsely advertised.
Monastra, Maria
core
Antibiotic therapy. By Henry Welch, Ph.D., Director, Division of Antibiotics, Food and Drug Administration, Federal Security Agency of the United States Government; and Charles N. Lewis, M.D., Medical Officer, Division of Antibiotics. 1951 The Arundel Press Inc., Washington. Pp. 562. $10.00 [PDF]
, 1952 openalex +1 more source
The First 18 Months Following Food and Drug Administration Approval of Lumbar Total Disc Replacement in the United States: Reported Adverse Events Outside an Investigational Device Exemption Study Environment [PDF]
, 2007 Scott L. Blumenthal +4 more
openalex +1 more source